http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8806863-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_62f75ed3333fbd223839fdc236484d56
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B10-0012
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-74
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B10-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00
filingDate 1988-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e8c52eb9176a377efc3cb974cb8abcec
publicationDate 1988-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-8806863-A1
titleOfInvention Fertility prediction by use of clomiphene challenge test
abstract The fertility of females, especially human females can be predicted by use of a clomiphene challenge test. The test is based upon comparison of follicle stimulating hormone and/or luteinizing hormone levels in urine or blood samples at two points in the menstrual cycle. Clomiphene, and most preferably clomiphene in the form of clomiphene citrate, in a dosage of about 100 mg/day, is then administered, preferably on days 5-9. The second test is conducted on days 9-10. The test results are most conveniently compared by colorimetric methods involving monoclonal antibody reactions with follicle stimulating hormone and/or luteinizing hormone.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5657762-A
priorityDate 1987-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4514505-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4278668-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4339434-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2800
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226421266
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1548955
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399016
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5757
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5994
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226421267
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399323

Total number of triples: 29.